Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

9.4%

5 terminated/withdrawn out of 53 trials

Success Rate

87.8%

+1.3% vs industry average

Late-Stage Pipeline

66%

35 trials in Phase 3/4

Results Transparency

3%

1 of 36 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3
29(61.7%)
Phase 2
8(17.0%)
Phase 4
6(12.8%)
N/A
4(8.5%)
47Total
Phase 3(29)
Phase 2(8)
Phase 4(6)
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (53)

Showing 20 of 53 trials
NCT06223919Phase 3Active Not Recruiting

Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia

Role: collaborator

NCT02276937Phase 2Unknown

Randomized Phase IIb Trial of DVC1-0101

Role: collaborator

NCT00905697Completed

Patient Reported Outcomes in Living Donor Lung Transplantation

Role: collaborator

NCT00905463Unknown

Prognosis of Lung Transplant Candidates

Role: collaborator

NCT02121327Not ApplicableCompleted

The Effects of Disease Management Programs for Prevention of Recurrent Ischemic Stroke

Role: collaborator

NCT00221104Phase 3Completed

Japan Statin Treatment Against Recurrent Stroke (J-STARS)

Role: collaborator

NCT00128037Phase 2Completed

Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806)

Role: collaborator

NCT00147134Phase 3Completed

A Trial to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer

Role: collaborator

NCT00190515Phase 3Completed

A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)

Role: collaborator

NCT00132613Phase 3Completed

Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion

Role: collaborator

NCT00145002Phase 3Completed

A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)

Role: collaborator

NCT00149279Phase 3Completed

A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer

Role: collaborator

NCT00144989Phase 3Completed

A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC

Role: collaborator

NCT00190528Phase 3Terminated

A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer

Role: collaborator

NCT00138008Phase 3Completed

Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy

Role: collaborator

NCT00112099Phase 3Completed

GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110

Role: collaborator

NCT00147121Phase 2Completed

Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)

Role: collaborator

NCT00132639Phase 2Completed

Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)

Role: collaborator

NCT00280475Phase 3Completed

A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metastasis

Role: collaborator

NCT00190541Phase 3Completed

Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)

Role: collaborator